Increased Ratio of Circulating T-Helper 1 to T-Helper 2 Cells and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction: A Prospective Observational Study.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
13 Aug 2019
Historique:
entrez: 14 8 2019
pubmed: 14 8 2019
medline: 23 2 2020
Statut: epublish

Résumé

BACKGROUND This study aimed to determine the association between CD4-positive T-helper (Th) cell subsets, T-helper 1 (Th1) and T-helper 2 (Th2) in patients with acute myocardial infarction (AMI) and the severity of coronary artery disease (CAD) determined by coronary artery angiography. MATERIAL AND METHODS Three groups of patients with AMI who underwent coronary angiography and percutaneous coronary intervention (PCI) included patients with stable CAD (n=35), ST-segment elevation myocardial infarction (STEMI) (n=30), and non-STEMI (NSTEMI) (n=35), and controls (n=33). Measurement of high-sensitivity cardiac troponin T (hs-cTnT) was performed. The numbers of circulating CD4-positive Th1 and Th2 cells were measured using flow cytometry. Plasma levels of interferon-γ (IFN-γ) and interleukin-4 (IL-4) were measured using enzyme-linked immunosorbent assay (ELISA). RESULTS An increase in the Th1 lymphocyte population was associated with more CAD, and an increased Th1/Th2 ratio was found in patients with NSTEMI and STEMI (controls 7.27±2.98; stable CAD 7.58±2.52; NSTEMI 16.62±2.74; and STEMI 22.32±7.35) (P<0.001). The proportion of Th1 cells and the Th1/Th2 ratio increased as the number of affected arteries, the degree of stenosis, and the lesion length increased. At a median follow-up of 18.2 months, patients with CAD and an increased Th1/Th2 ratio had a significant increase in adverse cardiac events compared with patients with a reduced Th1/Th2 ratio (log-rank, P=0.042). CONCLUSIONS An increased ratio of circulating Th1 to Th2 cells in patients with AMI was associated with the severity of CAD determined by angiography.

Identifiants

pubmed: 31407674
pii: 913891
doi: 10.12659/MSM.913891
pmc: PMC6703085
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

6034-6042

Références

Circulation. 2000 Dec 12;102(24):2919-22
pubmed: 11113040
Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):456-61
pubmed: 11884290
Nat Rev Immunol. 2002 Dec;2(12):933-44
pubmed: 12461566
Nature. 2002 Dec 19-26;420(6917):868-74
pubmed: 12490960
Cytokine. 2004 May 7;26(3):131-7
pubmed: 15135807
Hypertension. 2004 Sep;44(3):277-82
pubmed: 15302839
Circ Res. 2005 Mar 4;96(4):427-34
pubmed: 15662027
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1596-601
pubmed: 15665085
J Am Coll Cardiol. 2005 Jun 21;45(12):1939-45
pubmed: 15963390
J Clin Immunol. 2005 May;25(3):246-53
pubmed: 15981090
Scand J Immunol. 2006 Sep;64(3):336-44
pubmed: 16918703
J Cardiovasc Comput Tomogr. 2009 Mar-Apr;3(2):122-36
pubmed: 19272853
BMC Immunol. 2010 Dec 02;11:58
pubmed: 21126329
Atherosclerosis. 2011 Aug;217(2):518-24
pubmed: 21524750
PLoS One. 2012;7(10):e47193
pubmed: 23091611
Immunity. 2013 Jun 27;38(6):1092-104
pubmed: 23809160
Circulation. 2014 Apr 22;129(16):1677-87
pubmed: 24488984
J Immunol. 2015 Jan 15;194(2):499-503
pubmed: 25505286
J Clin Invest. 2015 Aug 3;125(8):3063-76
pubmed: 26168217
J Intern Med. 2015 Nov;278(5):483-93
pubmed: 26260307
Int J Clin Exp Med. 2015 Jul 15;8(7):10875-84
pubmed: 26379881
Nat Rev Cardiol. 2016 Mar;13(3):167-79
pubmed: 26525543
Circ Res. 2016 Feb 19;118(4):668-78
pubmed: 26892965
Circ J. 2016 May 25;80(6):1427-36
pubmed: 27118621
Immunobiology. 2016 Sep;221(9):1014-33
pubmed: 27262513
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Biomed Res Int. 2017;2017:4013685
pubmed: 28349060
Int J Cardiol. 2017 Sep 15;243:502-504
pubmed: 28615143
Nat Med. 2018 Jun;24(6):711-720
pubmed: 29867229
Int J Cardiol. 2019 Feb 1;276:289-292
pubmed: 30217424
Circulation. 1994 Jan;89(1):36-44
pubmed: 8281670

Auteurs

Chang Li (C)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Wenxia Zong (W)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Ming Zhang (M)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Yanming Tu (Y)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Qiyu Zhou (Q)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Mingke Ni (M)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Zhiyong Li (Z)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Haizhen Liu (H)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Jingyi Zhang (J)

Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China (mainland).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH